← Eichor
Study identifier: NCT06177184 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

DOnor Milk to REpair the Full-term Infant MIcrobiome in Infants Born Via Cesarean Section.

Condition: Microbial Colonization  ·  Sponsor: University of Calgary

PhaseNA
Planned participants90
Who can joinAll sexes, 37 Weeks to no upper limit
Healthy volunteersYes

About this study

The objective of this novel study is to establish proof of concept using a pilot randomized controlled trial to determine the effect of DHM compared to formula supplementation on the microbiome in full-term infants who are born via caesarean section and require supplementation. Secondarily, this study aims to compare the infant health outcomes of sleep and growth between groups to assess if these outcomes are mediated by infant feeding type or potential differences in microbial signatures. Finally, this study will compare maternal outcomes of depression, anger, breastfeeding self-efficacy and breastfeeding rates between groups. The infant gut microbiome plays a critical role in the developing immune, neurologic, and endocrine systems. Yet, most infants experience early life disruptions (ELDs) to their microbiome that have potential long-term health and development impacts. A major source of disruption is caesarean section (c-section) delivery because the infant is born surgically and is not exposed to important commensal bacteria required to establish the infant microbiome. Currently in Canada, over 28% of infants are born via c-section. Exclusive breastfeeding can improve gut microbiota composition in infants who are born via c-section. However, approximately 60% of infants born via c-section require formula supplementation in their first week of life. Evidence indicates that even one bottle of formula can further disrupt the gut microbiome. Donor human milk (DHM) is a su…

This description comes directly from the study's public registry record.

Talk to the study team

Meredith Brockway, PhD  ·  403-689-0970  ·  mbrockwa@ucalgary.ca

Jannette Festival, BN  ·  403-475-6455  ·  director@northernstarmilkbank.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Rockeyview General HospitalCalgary, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06177184